About LDN Research Trust
The primary aim of the Trust is to initiate Clinical Trials of Low Dose Naltrexone, help and support those who have a condition where LDN could be of benefit obtain a prescription around the world.
Download the LDN Information Pack which can be printed, to show your doctor.
Whilst working to raise funds for trials, we have helped over 18,000 people to obtain LDN from a General Practitioner or Neurologist, either through the National Health Service or by private prescription. We have also been able to help people, not just in the UK but in countries throughout Europe, as well as USA, Canada, West Indies, Australia, New Zealand, and others.
The mission of LDN aware is to spread public awareness of LDN worldwide.
Low dose naltrexone, where naltrexone is used in doses approximately one-tenth those used for drug/alcohol rehabilitation purposes, is being used as an "off-label" treatment for certain immunologically-related disorders. The use of LDN for such diseases as cancer was first proposed by Ian Zagon, PhD, and LDN's broader clinical effects in humans were proposed by Bernard Bihari, MD.
The LDN 2016 AIIC Conference in Orlando is now on sale.
February 19,20,21 DoubleTree Airport Hotel
To sign up and secure your tickets please click here.
This conference will review, compare and contrast the most recent data and treatments for a variety of Auto-Immune and Immuno-modulated Conditions.
This documentary was produced for the LDN Research Trust after it was funded successfully on Start Some Good.
It aims to explore some of the uses of LDN, encourage wider knowledge of LDN and educate watchers further with a view to encouraging clinical trials.